|
Volumn 76, Issue 12, 2001, Pages 1278-1279
|
Medical advice for international travelers
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMANTADINE;
INFLUENZA VACCINE;
OSELTAMIVIR;
RIMANTADINE;
SIALIDASE INHIBITOR;
ZANAMIVIR;
ANTIVIRUS AGENT;
SIALIDASE;
DIAGNOSTIC AGENT;
TUBERCULIN;
DISEASE TRANSMISSION;
DRUG COST;
DRUG MARKETING;
HUMAN;
INFECTION PREVENTION;
INFLUENZA;
LETTER;
PATIENT EDUCATION;
PEER REVIEW;
TRAVEL;
VACCINATION;
CROWDING;
DRUG ANTAGONISM;
DRUG STORAGE;
ECONOMICS;
NOTE;
PATIENT SELECTION;
RISK FACTOR;
SEASON;
VIROLOGY;
INCIDENCE;
MASS SCREENING;
METHODOLOGY;
MIGRATION;
PREVALENCE;
TUBERCULOSIS;
ANTIVIRAL AGENTS;
CROWDING;
DRUG COSTS;
DRUG STORAGE;
HUMANS;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
NEURAMINIDASE;
PATIENT EDUCATION;
PATIENT SELECTION;
RISK FACTORS;
SEASONS;
TRAVEL;
EMIGRATION AND IMMIGRATION;
INCIDENCE;
MASS SCREENING;
PREVALENCE;
TUBERCULIN;
TUBERCULOSIS;
|
EID: 0035648232
PISSN: 00256196
EISSN: None
Source Type: Journal
DOI: 10.4065/76.12.1278 Document Type: Letter |
Times cited : (4)
|
References (3)
|